What we're reading, June 21, 2016: potential Zika virus vaccine to be tested in humans; California regulator approved the potential merger between Aetna and Humana; and 5 states will be the testing ground for a new Medicare initiative to reduce fraud.
A vaccine to stop the Zika virus is now ready to be tested in humans. The study will include 40 healthy subjects and is designed to assess the safety of the vaccine and the immune response generated by the injection, reported The Washington Post. The vaccine was developed by Inovio Pharmaceuticals, of Pennsylvania, and GeneOne Life Sciences, of South Korea.
California’s state insurance commissioner may have come out against the Anthem-Cigna merger, but the state is taking a different stance on Aetna’s proposed acquisition of Humana. According to the Los Angeles Times, the director of the California Department of Managed Health Care is approving the Aetna-Humana merger. Aetna has agreed to give greater state oversight of rates. The Department of Justice still has to approve the merger.
Five states will be the testing grounds for a new Medicare initiative to reduce fraud. The Dallas Morning News reported that home health providers in Texas, Illinois, Florida, Michigan, and Massachusetts will be required to send every claim to be reviewed before Medicare pays. However, some are concerned that the program could put beneficiaries at risk of being discharged if claims are not approve in a timely manner.
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen